Pfizer's Dr Emma Andrews is the vice president of global patient advocacy. In the first of a two-part interview with BioPharmaDispatch, Dr Andrews discusses patient literacy, advocacy, and the importance of listening to patients and not talking at them.
Pfizer's Dr Emma Andrews on the importance of listening more and talking less
June 30, 2023 Latest NewsBioPharmaBioPharmaDispatch ExecutiveNews of the Day
Latest Video
New Stories
-
Priceline moves to stabilise banner group as pressures force administrators
December 17, 2025 - - Latest News -
Rare Cancers Australia gearing up for 2026 Kosi Challenge with Pharma Cup up for grabs again
December 17, 2025 - - Latest News -
Ferronova secures funding to advance nanoparticle technology for cancer surgery
December 17, 2025 - - Australian Biotech -
Antimalarial candidate under WEHI-MSD partnership offers fresh hope against resistance
December 17, 2025 - - Latest News -
OncoSil completes first production run at new Sydney manufacturing facility
December 17, 2025 - - Australian Biotech -
Budget update repeats the 'fiscal illusion' that has become PBS spending
December 17, 2025 - - Latest News -
Island Pharmaceuticals secures key partnership with Texas Biomed
December 17, 2025 - - Australian Biotech

